- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07908602
Hip Muscle Strengthening and Calf Myofascial Release in Females With Chronic Plantar Fasciitis
Effects of Hip Muscle Strengthening With and Without Myofascial Release of Calf Muscle on Pain and Disability in Females With Chronic Plantar Fasciitis.
This study aims to compare the effects of hip muscle strengthening with and without myofascial release of the calf muscle on pain and disability in females with chronic plantar fasciitis.
Chronic plantar fasciitis is a common cause of heel pain and may lead to limitations in walking, daily activities, and functional performance. Factors such as calf muscle tightness, restricted ankle dorsiflexion, altered lower-limb biomechanics, and proximal hip muscle weakness may contribute to persistent symptoms. Although strengthening exercises and myofascial release have shown beneficial effects, limited evidence is available regarding the combined effect of hip strengthening and calf myofascial release in females with chronic plantar fasciitis.
The study will be conducted as a randomized clinical trial with a total sample of 34 females, aged 25-45 years, who meet the specified criteria for chronic plantar fasciitis. Participants will be randomly allocated into two groups. Group A will receive hip muscle strengthening exercises, while Group B will receive the same strengthening program combined with myofascial release of the calf muscles. Both groups will receive treatment three times per week for six weeks, for a total of 18 sessions.
The primary outcome measures will include the Numeric Pain Rating Scale (NPRS), Foot Function Index (FFI), and Morning First-Step Pain Visual Analogue Scale (VAS). Assessments will be performed at baseline and after completion of the six-week intervention.
Studienübersicht
Status
Bedingungen
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- UMT
-
Kontakt:
- Fizza Masood Dr., MS-OMPT
- Telefonnummer: +923344318731
- E-Mail: fizza.masood@umt.edu.pk
-
Kontakt:
- Rabia Jawa CoD Physical Therapy and Rehabilitation, MPhil PT
- Telefonnummer: +923434570838
- E-Mail: rabia.jawa@umt.edu.pk
-
Unterermittler:
- Sadia Riaz
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Participants fulfilling the diagnostic criteria for plantar fasciitis.
- Age between 25-45 years.
- NPRS score between >3-6.
- History of chronic plantar heel pain for at least 3 consecutive months.
- Positive Windlass Test.
- Morning first-step pain intensity >5 cm on a 10-cm Visual Analog Scale (VAS).
Exclusion Criteria:
- Recent history of foot, ankle, or lower limb surgery.
- Corticosteroid injection for plantar fasciitis within the previous three months.
- Diagnosed neurological disorders affecting lower limb function.
- Pregnancy.
- Heel pain due to any other systemic inflammatory condition such as rheumatoid arthritis, gout, hyperuricemia (uric acid disorders), or other causes of heel pain.
- Foot or ankle fracture within the previous six months.
- Participation in any structured physiotherapy program for plantar fasciitis during the previous month.
- Presence of tarsal tunnel syndrome, Achilles tendon rupture, or other significant foot pathologies.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Arm 1: Hip muscles Strengthening Exercises
Participants will receive hip abductor strengthening exercises three sessions per week for six weeks to improve pain and functional outcomes associated with chronic plantar fasciitis. |
hip abductor strengthening exercises three sessions per week for six weeks |
|
Aktiver Komparator: Arm 2: Hip muscles Strengthening Exercises Combined with Calf Myofascial Release
Participants will receive hip muscles strengthening exercises combined with myofascial release of the calf muscles three sessions per week for six weeks to evaluate the additional effects of calf myofascial release on pain and functional outcomes associated with chronic plantar fasciitis. |
hip muscles strengthening exercises combined with myofascial release of the calf muscles three sessions per week for six weeks |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Numeric Pain Rating Scale (NPRS)
Zeitfenster: Baseline and after 6 weeks
|
The Numeric Pain Rating Scale (NPRS) will be used to assess the intensity of pain associated with chronic plantar fasciitis. It is an 11-point numerical scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate greater pain intensity. |
Baseline and after 6 weeks
|
|
Foot Function Index (FFI)
Zeitfenster: Baseline and after 6 weeks
|
The Foot Function Index (FFI) will be used to assess foot-related pain, disability, and activity limitation in females with chronic plantar fasciitis. The questionnaire evaluates the impact of foot symptoms on functional activities. Higher scores indicate greater pain and functional limitations. |
Baseline and after 6 weeks
|
|
Morning First-Step Pain Visual Analog Scale (VAS)
Zeitfenster: Baseline and after 6 weeks
|
The Visual Analog Scale (VAS) will be used to assess pain experienced during the first steps taken in the morning after a period of rest. Participants will indicate their pain intensity on a 10-cm visual analog line, with one end representing no pain and the other representing the worst imaginable pain. Higher scores indicate greater morning first-step pain. |
Baseline and after 6 weeks
|
Mitarbeiter und Ermittler
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- RE-165-2026
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
The results data collected , de-identified individual participant data will be shared.
IPD-Sharing-Zeitrahmen
6 months after the publication of the manuscript.
IPD-Sharing-Zugriffskriterien
The data can be requested from the corresponding author.
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- SAFT
- ICF
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .